27 June 2019
Read more
Mark Helyar
Of Counsel

Mark has a particular specialisation in the use of protected cell companies (PCCs) for investment funds and insurance purposes and assisted in drafting the 2006 Guernsey law relating to incorporated cell companies. He has substantial expertise in corporate, commercial and investment fund practices.
Mark is regularly instructed by foreign regulatory authorities and governments on the implementation of segregated cell company legislation.